2018 February

WASHINGTON — A new report out from the Governors Highway Safety Association finds that driving while on drugs, even marijuana, poses a significant safety risk on our roadways, on par with drunken driving.

Researchers found that the percentage of drivers killed who tested positive for drugs is almost the same as those who tested positive for any alcohol — 40 percent.  More than 5,000 drivers killed each year have drugs in their system at the time of the crash.

“The proportion with drugs in their system has increased over the past several years and now the level is about the same with alcohol in their systems,” says Dr. Jim Hedlund, author of the report.

The report puts a special emphasis on marijuana use and its impact on driving because lawmakers across the country are debating whether to legalize the drug.

“The evidence is very clear that marijuana affects decision times, reaction times and so forth.  If you are using marijuana, you are at an increased risk of being in a crash,” says Hedlund.

He is particularly concerned that lawmakers are not considering the impact of marijuana on deadly crashes when talking about legalizing the drug.  Hedlund also says the laws on the books for drug-impaired driving need to be clearer and more in line with drunken driving laws.

“Every state must take steps to reduce drug-impaired driving, regardless of the legal status of marijuana,” says Jonathan Adkins, executive director of GHSA.

“This is the first report to provide states and other stakeholders with the information that they need.  And we encourage [the National Highway Traffic Safety Administration] to issue guidance on best practices to prevent marijuana-impaired driving.  We look to the federal government to take a leadership role in this issue similar to that of drunk driving and seat belt use,” he adds.

The report calls on states to take several measures to address the issue head-on.  It urges states to assess the data in their region, examine and update drug-impaired driving laws, test all drivers who are killed in a crash for drugs and separate statistics between drunken driving from driving while on drugs.

Source:    Governors Highway Safety Association  Sept.2015

Haven Dubois, 14, died in accidental drowning on May 20, 2015, coroner says

Family members hold a picture of Haven Dubois, 14, who was found in cardiac arrest in a Regina creek on May 20, 2015. (CBC)

Richelle Dubois, the mother of 14-year-old Haven Dubois, says she is determined to learn more about the circumstances surrounding her son’s death. “I’m not done with this until I’m satisfied that they’ve looked into everything,” Dubois said Wednesday following the release of a coroner’s report that looked into the May 20, 2015 death of Haven. “I need to make sure that they’ve done their job properly.”
According to the report, the Regina boy was found drowned. The report said boys who were with Haven on that day told the coroner that he suffered a bad reaction to marijuana.
The boy’s mother Dubois has expressed concerns the death might have been connected to gangs. Police said foul play had been ruled out. Richelle Dubois said last fall she had waited a long time for the coroner to complete her report on her son Haven’s death. (CBC)
Coroner Maureen Stinnen interviewed a number of boys who were with Dubois, who said he was at school in the morning before getting into a car with friends.
“They apparently smoked some marijuana and they indicated that Haven began ‘freaking out,'” Stinnen’s report said. One of the youths Stinnen interviewed said it was Dubois’s first time smoking drugs. After getting out of the car, Dubois continued suffering ill effects and started walking away from the school, F. W. Johnson Collegiate.

Left alone on a bench

“Witnesses indicate he was ‘spinning in circles’ with his arms crossed at his chest,” the report said. One witness said he sat for a while with Dubois on a bench in a park, but left him alone so he could go get a skateboard and backpack. When the boy returned, Dubois wasn’t at the bench.
A friend said he last saw Dubois walking north by the creek in the area where his mother had discovered the body. Over the noon hour, Dubois was found face down in about a metre of water. Efforts to resuscitate him failed.
Dubois had no history or depression or suicidal tendencies, the coroner said. However, a toxicology report indicated he had the active component of cannabis in his blood.

Reactions to marijuana vary, coroner says

“The effect of marijuana on individuals varies considerably, from minor effects such as general feeling of well-being, to agitation and paranoia,” the report said. “These effects are subject to dose, age and experience of the user. Even in low doses, marijuana can precipitate a panic reaction and irrational behaviour.”
Stinnen said the case was thoroughly investigated by the Regina police and while “questions remain,” there were no indications of foul play. She concluded that Dubois’s death was an accidental drowning with drug use a “significant contributing factor.”

Mother seeks more information

Richelle Dubois said Wednesday she feels she did not get enough information from police about their investigation. “It’s so easy for them to brush it aside. It’s just another dead Indian to them,” Dubois said. “That’s how I feel; that we’re just another Indian family.”
According to a spokesperson from the police, officers met with Dubois three times. Dubois said the findings of the coroner, noting how marijuana can lead some people to panic and act irrationally, provide a possible explanation for her son’s death, but she still has questions.
“l know this isn’t the end of it,” she said. “This little two and a quarter page [report] isn’t the end of it.” Dubois added she has made a formal request to view police reports on the case.

Source: http://www.cbc.ca/news/canada/saskatchewan/marijuana-significant-factor-in-haven-dubois-death-1.3392179

Proponents raised $7.6 million to opponents’ $169,000 to legalize marijuana for recreational use, a ratio of 45 to 1. Opponents in Alaska and Oregon could not afford to present other viewpoints in TV commercials. Meanwhile, after just ten months of legal marijuana, five Colorado cities passed amendments to ban the sale of recreational marijuana within their borders. The Republican gubernatorial challenger ran on a platform calling for the repeal of legalization. As citizens’ anger mounts over outsiders sweeping in, getting what they want, and leaving behind a mess for taxpayers to clean up, we are likely to see more of that.

Alaska Legalizes Recreational Marijuana–You might think the 23 states that have legalized marijuana were responding to citizen demand. You would be wrong. The Drug Policy Alliance and the Marijauna Policy Project, their funders George Soros and the late Peter Lewis, a by-now burgeoning marijuana industry, and an estimated $200 million are behind the drive to legalize marijuana. Imagine a Congress where all 435 Representatives and 100 Senators belong to just one party, and you can begin to understand how one-sided marijuana initiatives have been.

Source:  TheMarijuanaReport.org  Nov. 2014

 

Big Business made a lot of money out of selling tobacco products  –  and it took many years before the link between smoking and  cancer were accepted.   Big Pharma make a lot of money from selling pharmaceutical drugs.  Big Business Mark II intends to make a lot of money out of selling marijuana (cannabis) products – regardless of the research that now shows this substance is not harmless.

The graphics above show just how much money was spent by the proponents of drug legalisation compared to the amounts that those who oppose legalisation were able to muster from grass roots supporters.   It is not surprising that so many of the American public were hoodwinked into voting for easier access to drugs – beginning with marijuana but eventually all currently illegal substances.

There was much misinformation, errors of omission and emphasis on ‘ individual freedoms’ – and no information about scientific research showing the dangers – particularly to young people – of using marijuana.

Already there are signs of discontent in many places with legalised marijuana – more driving accidents,  more instances of children being made ill from consuming what appeared to be sweets but was in reality marijuana packaged as a candy or chocolate bar …..how long will it be before the

Pandora’s Box can be tightly closed ?

National Drug Prevention Alliance   November 2014

Xcel Energy utility officials say lighting companies working with cannabis growers are testing LED lamps that require less electricity

DENVER, CO – DECEMBER 02: Denver Fire Department Lieutenant, Tom Pastorius, does an inspection of a Denver marijuana grow operation, December 02, 2014. Local government officials from Denver to smaller cities and rural hamlets say the pivotal first-year rollout went smoothly in most cases. (Photo by RJ Sangosti/The Denver Post)

GOLDEN — Surging electricity consumption by Colorado’s booming marijuana industry is sabotaging Denver’s push to use less energy — just as the White House perfects a Clean Power Plan to cut carbon pollution.

Citywide electricity use has been rising at the rate of 1.2 percent a year, and 45 percent of that increase comes from marijuana-growing facilities, Denver officials said Wednesday.

Denver has a goal of capping energy use at 2012 levels. Electricity is a big part of that.

The latest Xcel Energy data show cannabis grow facilities statewide, the bulk of which are in Denver, used as much as 200 million kilowatt hours of electricity in 2014, utility officials said. City officials said 354 grow facilities in Denver used about 121 million kwh in 2013, up from 86 million kwh at 351 facilities in 2012.

“Of course we want to grow economically. But as we do that, we’d like to save energy,” city sustainability strategist Sonrisa Lucero said.

She and other Denver officials joined 30 business energy services and efficiency leaders seeking U.S. Department of Energy guidance Wednesday at a forum in Golden. Energy Undersecretary Franklin Orr said feds will promote best practices and provide technical help through an Office of Technology Transitions.

“It’s a big issue for us,” Lucero told Orr. “We really do need some assistance in finding some good technology.”

Orr said he tried to figure out “how we would address that to Congress.”

When the EPA later this summer unveils the Clean Power Plan for state-by-state carbon cuts and installation of energy-saving technology, utilities are expected to accelerate a shift away from coal-generated electricity toward cleaner sources, such as natural gas, wind and solar.

Until they can replace more coal-fired plants, the nation’s utilities increasingly are trying to manage demand by, for example, offering rebates to customers who conserve electricity.

Colorado for years has been encouraging cuts in carbon emissions by requiring utilities to rely more on renewable sources.

Yet electricity use statewide has been increasing by 1 percent to 2 percent a year, due in part to population growth, said Jeffrey Ackermann, director of the Colorado Energy Office.

The rising electricity demand means more opportunities to save money by using energy more efficiently , Ackermann said. “We’re not going to compel people to reduce their usage. … But we’re going to try to bring efficiency into the conversation.”

Colorado’s marijuana sector, in particular, is growing rapidly, relying on electricity to run lights that stimulate plant growth, as well as air-conditioning and dehumidifiers. The lights emit heat, raising demand for air conditioning, which requires more electricity.

“How do you capture their attention long enough to say: Hey, if you make this investment now, it could pay back in the future,” Ackermann said, referring to possibilities for better lights.

Southwest Energy Efficiency Project director Howard Geller said new adjustable light-emitting diode, or LED, lights have emerged that don’t give off heat. Companies installing these wouldn’t require so much air-cooling and could cut electricity use, Geller said.

Lighting companies are working with pot companies to test the potential for LED lamps to reduce electricity use without hurting plants, Xcel spokesman Mark Stutz said. Xcel is advising companies on how much electricity different lights use, he said.

Denver officials currently aren’t considering energy-efficiency rules for the industry, said Elizabeth Babcock, manager of air, water and climate for the city. Marijuana-growing facilities in 2013 used 1.85 percent of total electricity consumed in Denver.

“We see many opportunities in all sectors,” Babcock said. “Energy efficiency lowers the cost of doing business, and there are lots of opportunities to cut energy waste in buildings, transportation and industry.”

Source:    www.denverpost.com   7th January 2015

My blood boils when I hear loony liberal politicians (I’m thinking Nick Clegg) and middle class do-gooders telling us that ALL drugs should be legalised. That heroin, crack cocaine and LSD should all be freely available – even to teenagers.

Their argument is that if the State was in charge of the drugs industry instead of criminal gangs then the drugs wouldn’t be toxic and fewer people would die.

And there’ll be more of that silly talk in the coming weeks thanks to a Home Office report – trumpeted by Clegg – which claims punitive laws have no effect on curbing drug use.

What, so do we just give up and legalise them? If we can’t win the war on drugs do we just call it off? Do we do what we’ve done with other crimes we don’t have the money or the will to police – and just ignore them?

One of the countries cited as an example of decriminalisation in this report was Portugal. They legalised drugs in 2001. But now we know the numbers of 15 and 16 year olds using drugs has doubled there since laws were relaxed. Which is a total no brainer.

Then a bloke called Ian Birrell said on TV this week our Government spends billions of pounds on failed drugs policies. I’m sorry – unlike Portugal – our drugs policies aren’t failing. Since 1996 the use of Class A drugs among 16 to 24 year olds has plummeted by 47 per cent and the use of Class B by 48 per cent.

But commentators like Birrell still argue we should legalise them anyway because they’re everywhere and people can take them whenever they want. Well, maybe in his world they can, but not in mine. I don’t mix with people who shoot up every day or trip on LSD.

Don’t these lettuce-munching liberals realise millions of mums and dads all over Britain are fighting tooth and nail to keep their kids away from drugs?

And even though many of these parents live on estates where gangs sell drugs openly they’ll do ­whatever it takes to keep their kids away from them. Because they’ve seen what drugs can do.

Unlike those middle-class liberals, they live among hordes of hopelessly addicted youngsters whose lives are over before they’ve even started. These parents don’t want that for their kids. And they sure as hell don’t want to be lectured on the “benefits” of legalisation by a bunch of jumped-up modernisers who’ve never even set foot on a council estate.

PA

Should this be legal? Ecstasy Tablets 

Have we forgotten the World Health Organisation’s recent 20-year study on cannabis which says this supposedly “soft” drug doubles the risk of schizophrenia and psychotic ­disorders, stunts intellectual ­development and doubles the risk of its users causing a car crash?

So all those liberals who for years have been shouting that cannabis was perfectly safe were talking out of their backsides.

And why is it these people always try to make those who object to legalisation look like out of touch fuddy-duddies? Why do we listen when they scream that drugs laws are an abuse of our human rights?

We need to be telling teenagers that smoking cannabis is like playing Russian roulette with your brain, not changing the law so they can pop down the Co-op and score an ounce.

Yes, young people will always­ ­experiment with drugs but why make it easier? We need drugs laws because they make getting drugs just that bit harder. In fact, we need more than we currently have to criminalise those deadly legal highs which have killed 68 people this year.

And imagine if they WERE all ­legalised. The price would plummet and they’d be available to everyone including vulnerable 10-year-olds who’d buy them with their pocket money on the black market.

I’m not saying kids should be given criminal records for experimenting. But every little relaxation of our drugs laws takes us one step closer to ­legalisation.

And that would be catastrophic for ­generations of children whose minds will be ravaged with the full blessing of the State.

Source:  Mirror.co.uk   Nov. 1st 2014Top of Form

By Fabrizio Schifano Chair in Clinical Pharmacology and Therapeutics at University of Hertfordshire

Fabrizio is a member of the UK advisory council on the misuse of drugs. He has also received EC funding in relation to researching the effects of novel psychoactive substances. These views are his own and in no way represent either the council or the EC.

In one respect, the world’s drug problem is not getting much worse. The UN believes that the use of drugs such as cocaine and heroin has stabilised, for example. In fact, the ground in the drugs battle has just shifted. The focus is now increasingly on legal highs.

People might be aware that altered versions of ecstasy or cannabis are available nowadays, but the true range of what we in the trade call novel psychoactive drugs is far more varied. There are derivatives of everything from ketamine to cocaine, from opiates to psychotropics. Their use is rising, and so is the number of fatalities. Some people fear that the figures are only going in one direction.

Enforcers vs chemists

Why has this happened? In recent years there was a worldwide decrease in the purity of drugs like amphetamine and cocaine and the MDMA content of ecstasy. This decrease helped fuel demand for alternatives (though admittedly there are signs that this purity decrease is now reversing). The internet has also made possible the sort of sharing of information that makes it much easier to sell these substances nowadays. And as has been well documented, banning these drugs is difficult because the manufacturers can constantly bring out new varieties with slight alterations to the chemistry.

It has turned into a battle between the drug enforcers and the drug chemists, who are typically based in the Far East, for example in China and Hong Kong. There are many databases online with information on the molecular structures of existing drugs. This makes it easier for these people to modify them to create a new product.

The market is very strong in the UK. You might think it is because the information online is often written in English. This would explain why Ireland has a big problem too, but then again the US does not. And other problem countries includeLatvia, Hungary, Estonia and Russia.

The big worries

Certain categories particularly worry us. One is the ecstasy derivatives known as phenethylamines. One of the well-known ones in the UK is PMA, which has been nicknamed “Dr Death” because of the number of fatalities. Another is known as “blue mystique”. These have been made illegal in a number of European countries, but many more keep appearing. A related group is known as NBOMe, which are very powerful and therefore also a great concern.

Then there are cannabimimetics, which are sometimes known as the “spice drugs”. There are a few hundred known variations, many of which are very powerful, sometimes thousands of times more than cannabis. They were behind the “spiceophrenia” epidemic in Russia, but are prevalent closer to home too. Last week a new HM Prisons report mentioned them among a number of legal-high concerns in British prisons. To make matters worse, they are very easy to modify and have the big selling point that they can’t always be traced in urine.

Sometimes legal highs are marketed as a solution to a problem that an illegal drug might cause. For example ketamine (“special K”) is known to damage the intestine and bladder, so a new drug reached the market called methoxetamine, or “special M,” which claimed to be bladder-friendly. But in fact it is still toxic for the bladder and also the kidney and central nervous system. And after it was made illegal, a number of other derivatives appeared such as diphenidine. The health risks associated with this class makes the new versions particularly scary.

The unwinnable battle?

We often don’t know how these drugs affect people. Researchers like myself are working on this, but the number of new substances is increasing too quickly for us to keep up. By the time we publish papers focusing on more popular versions, the market has changed. When something goes wrong, doctors don’t know how to treat the effects – in many cases they can’t even ascertain the exact drug.

We have reached the point where I am now more worried about legal highs than illegal drugs. Whenever I see a heroin client in my clinic, I know exactly what to do. That is often not the case with legal highs. And as a psychiatrist I know that they potentially have far more psychiatric consequences than heroin. Whenever you tamper with very sensitive mechanisms in your brain, it’s difficult to know what will happen.

One argument is that we should keep these drugs legal since we are facing an unwinnable battle. But the big drawback with this is that it makes adolescents and other susceptible people think that the drug must be safe. New Zealand tried this approach by permitting drugs to remain in circulation if the producers could demonstrate they were low risk, but this year the government U-turned after there were a number of adverse incidents. Now its approach is similar to the UK with its expanding prohibition schedule.

The problem with the New Zealand low-risk policy is that establishing the safety of a drug is a very slow process if you are going to do it properly. Proving through clinical trials that a drug works, is safe and is not toxic takes upwards of 10 years. Anything less would be cutting corners. If a manufacturer were to go through that process and prove that a drug was low risk, that might be a different discussion, but it’s not going to help with today’s problem.

Similarly there has been some debate about permitting the supply of legal highs but keeping it tightly restricted – perhaps allowing one distributor per town, for example. But this both ignores the reality of the internet and offers no answer to the safety problem.

Another possibility is to legalise the illegal drugs that we know much more about, so that people are encouraged to take them instead. But even if this was politically possible, it doesn’t sound like the right course of action either. I see disasters from drug-taking on a daily basis. And it wouldn’t necessarily stop people from taking legal highs anyway.

The answer to what we actually should do is complex. The answer probably lies in prevention: we need dedicated resources and funding, we need new ideas to try and convince youngsters that these drugs are not safe just because they are legal. This requires a big change in how we see these substances. These are not just some marginal concern. This is the new drug battle for the decades ahead.

Source:  http://theconversation.com/legal-highs-regulation-wont-work  29th October 2014

There has been a lot of talk recently about marijuana legalization — increasing tax revenue for states, getting nonviolent offenders out of the prison system, protecting personal liberty, possible health benefits for those with severe illnesses. These are good and important conversations to have, and smart people from across the ideological spectrum are sharing their perspectives.

But one key dimension of the issue has been left out of the discussion until now: the marketing machine that will spring up to support these now-legal businesses, and the detrimental effect this will have on our kids.

Curious how this might work? Look no further than Big Tobacco. In 1999, the year after a massive legal settlement that restricted certain forms of advertising, the major cigarette companies spent a record $8.4 billion on marketing. In 2011, that number reached $8.8 billion, according to the Campaign for Tobacco-Free Kids. To put it into context, the auto industry spent less than half of that on advertising in 2011, and car ads are everywhere.

At the same time, despite advertising bans, these notoriously sneaky tobacco companies continue to find creative ways to target kids. Data from the 2011 National Survey on Drug Use and Health found that the most heavily marketed brands of cigarettes were also the most popular among people under 18.

This is not a coincidence, and gets to the very core of Big Tobacco’s approach: Hook them young, and they have a customer for life. Why do we think the legal marijuana industry will behave differently from Big Tobacco? When the goal is addiction, all bets are off.

In Colorado, where there are new rules governing how legal marijuana is advertised in traditional media, there are still many opportunities to market online and at concerts, festivals and other venues where kids will be present. Joe Camel might be retired, but he’s been replaced by other gimmicks to get kids hooked — like snus and flavored cigarettes. The marijuana industry is following suit by manufacturing THC candies, cookies, lollipops and other edibles that look harmless but aren’t. Making marijuana mainstream will also make it more available, more acceptable and more dangerous to our kids.

Addiction is big business, and with legal marijuana it’s only getting bigger.

Not surprisingly, Big Tobacco is also getting on the marijuana bandwagon. Manufacturers Altria and Brown & Williamson have registered domain names that include the words “marijuana” and “cannabis.” Imagine how much they will spend peddling their new brand of addiction to our kids. We cannot sit by while these companies open a new front in their battle against our children’s health.

Why is this an issue? There is a mistaken assumption that marijuana is harmless. It is not. Marijuana use is linked with mental illness, depression, anxiety and psychosis. It affects parts of the brain responsible for memory, learning, attention and reaction time. Developing brains are especially susceptible to all of the negative effects of marijuana and other drug use. In fact, poison control centers in Colorado and Washington state have seen an increase in the number of calls regarding marijuana poisoning. This isn’t a surprise — with legal marijuana comes a host of unintended consequences.

I’ve spent the past several years after leaving Congress advocating for a health care system that treats the brain like it does any other organ in the body. Effective mental health care, especially when it comes to children, is critically important.

Knowing what we now know about the effects of marijuana on the brain, can we really afford to ignore its consequences in the name of legalization? Our No. 1 priority needs to be protecting our kids from this emerging public health crisis. The rights of pot smokers and the marijuana industry end where our children’s health begins.

I’m not alone in my concerns about this trend toward legalization. Even Colorado Gov. John Hickenlooper has said that marijuana legalization in his state was “reckless” and reaffirmed his opposition to it during his campaign for re-election. He also said he will “regulate the heck” out of it. For that, I applaud his leadership and courage.

Alaska, Oregon and the District of Columbia have legalization ballot measures up for a vote this fall. I hope common sense will prevail, and they choose a better path than making addiction the law of the land.

At the end of the day, legalizing and marketing marijuana is making drug use acceptable and mainstream. Just as Big Tobacco lied to Americans for decades about the deadly consequences of smoking, we can’t let “big marijuana” follow in its footsteps, target our kids and profit from addiction.

Patrick J. Kennedy is a former United States representative from the state of Rhode Island.

Source: http://www.npr.org/2014/10/30/360217001/kennedy-are-we-ready-for-big-tobacco-style-marketing-for-marijuana

 

AS THE LEGAL AND MEDICAL USE OF MARIJUANA BECOMES MORE COMMONPLACE, OFFICIALS ARE STRUGGLING TO DETERMINE AND ENFORCE SAFE LEVELS OF IMPAIRMENT.

Determining how intoxicated someone is can be quite a difficult task. For alcohol consumption, a substance that the body excretes in a quick, linear fashion, we can measure the amount of metabolic by-products present in the blood using a breathalyzer, or directly measure ethanol levels with a blood test.

Although the issue is somewhat complicated by differing tolerances, research conducted throughout the 20th century showed that nearly everyone loses their ability to drive safely above certain blood alcohol levels.

In the US, medical marijuana is legal in 29 states and adult recreational use is legalized in eight. Widespread popularity of this psychoactive drug seems to necessitate a similar method for measuring whether or not someone is too high to drive.

Actually creating a “weed breathalyzer” or other marijuana field sobriety test, however, is fraught with scientific complications. According to a commentary published in Trends in Molecular Medicine, the main psychoactive compound in marijuana, THC, not only lingers in the body inconsistently, it also has unpredictable cognitive effects between users.

Early medical studies implied that THC could be detected in the blood for approximately six hours after smoking. Yet subsequent work by the article’s co-author, Marilyn Huestis, found that behavioral changes and motor impairments may last 6-8 hours after smoking despite near zero blood levels after just 2.5 hours.

Even if THC blood levels could accurately judge impairment, taking blood samples after a suspicious accident is likely to be fruitless for law enforcement.

“[Blood levels decline by] 74 percent in the first 30 minutes, and 90 percent by 1.4 hours,” said Huestis to Wired. “And the reason that’s important is because in the US, the average time to get blood drawn [after arrest] is between 1.4 and 4 hours.”

So why do people continue to feel stoned long after the drug is gone from the blood? Unlike ethanol, a hydrophilic molecule, THC doesn’t like hanging out in the water-based blood plasma and rapidly distributes into the cells of lipophilic fatty tissues, organs, and the brain.

“In fact, individual experiences reflect two different levels of drug ‘high,’” the article states. “..Namely a low ‘high’ effect in the absorption phase during cannabis inhalation, and a much higher effect later during the distribution phase owing to the lag time for full distribution of the active THC to the site of action – in this case, the brain.”

Furthermore, the body does not metabolize all the THC absorbed by body tissues at the time of smoking, vaping, or eating; the excess is slowly broken down over days to weeks. Heavy cannabis users will develop a THC tolerance due to this chronic, low-level exposure.

Consequently, occasional users and heavy users may feel wildly different effects from consuming the same dose of THC, preventing determination of a universal, safe dosage cut-off for drivers. A national poll from 2017 suggests that half of Americans are unconcerned by the prospect of stoned drivers on the roads, but law enforcement officials in many US states have drug-impaired driving laws that they intend to enforce. So, what tools should they use?

Huestis, who is also a senior investigator at the National Institute on Drug Abuse, does not support a legal driving limit for marijuana. She believes that, currently, well-trained police officers are best-suited for recognizing signs of impairment. Meanwhile, researchers such as herself are working to identify biomarkers that are more representative of the drug’s cognitive effects than blood THC. Ideally, these can then be measured using rapid non-invasive tests.

Another interesting prospect: Researchers at University of California San Diego are recruiting participants for a trial to develop an iPad-based cannabis-specialized field sobriety test. Volunteers will randomly receive marijuana joints at various THC concentrations, then complete driving simulations and undergo experimental impairment assessments.

Source: http://www.iflscience.com/health-and-medicine/why-is-it-so-hard-to-test-for-marijuana-intoxication/ January 2018

One in five Canadians between 15 and 24 years of age reports daily or almost daily use of cannabis prior to legalization. They see it as “much safer than alcohol and tobacco” and “not as dangerous as drunk driving.”

Author 1. Paul W Bennett

Research Associate in Education, Saint Mary’s University

Disclosure statement

Paul W Bennett does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Partners

The Conversation UK receives funding from Hefce, Hefcw, SAGE, SFC, RCUK, The Nuffield Foundation, The Ogden Trust, The Royal Society, The Wellcome Trust, Esmée Fairbairn Foundation and The Alliance for Useful Evidence, as well as sixty five university members.

One of the enduring myths about marijuana is that it is “harmless” and can be safely used by teens.

Many high school teachers would beg to disagree, and consider the legalization of marijuana to be the biggest upcoming challenge in and around schools. And the evidence is on their side.

As an education researcher, I have visited hundreds of schools over four decades, conducting research into both education policy and teen mental health. I’ve come to recognize when policy changes are going awry and bound to have unintended effects. As Canadian provinces scramble to establish their implementation policies before the promised marijuana legalization date of July 2018, I believe three major education policy concerns remain unaddressed.

These are that marijuana use by children and youth is harmful to brain development, that it impacts negatively upon academic success and that legalization is likely to increase the number of teen users.

‘Much safer than alcohol’

Across Canada, province after province has been announcing its marijuana implementation policy, focusing almost exclusively on the control and regulation of the previously illegal substance. This has provoked fierce debates over who will reap most of the excise tax windfall and whether cannabis will be sold in government stores or delegated to heavily regulated private vendors.

All of the provincial pronouncements claim that their policy will be designed to protect “public health and safety” and safeguard “children and youth” from “harmful effects.”

Still, one in five young people between 15 and 24 years of age, according to a recent national study, report daily or almost daily use of cannabis.

They also see marijuana as “much safer than alcohol and tobacco” and “not as dangerous as drunk driving.”

Few either know about or seem concerned over the clear linkage between heavy use and early-onset psychosis.

Early-onset paranoid psychosis

So what does the evidence say? First, heavy marijuana use can, and does, damage brain development in youth aged 13 to 18. A 2015 Canadian Centre on Substance Abuse study confirmed the direct link between cannabis use and loss of concentration and memory, jumbled thinking and early onset paranoid psychosis.

One of the leaders in the medical field, Dr. Phil Tibbo, initiator of Nova Scotia’s Weed Myths campaign targeting teens, has seen the evidence, first hand, of what heavy use can do as director of Nova Scotia’s Early Psychosis Program. His brain research shows that regular marijuana use leads to an increased risk of developing psychosis and schizophrenia and effectively explodes popular and rather blasé notions that marijuana is “harmless” to teens and “recreational use” is simply “fun” and “healthy.”

Damaging to academic performance Second, marijuana negatively impacts neurocognitive performance in teens and users perform more poorly in quantitative subjects requiring precision — like mathematics and senior science.

In 2017, Dutch researchers Olivier Marie and Ulf Zolitz found that the academic performance of Maastricht University students increased substantially when they were no longer legally permitted to buy cannabis. The effects were stronger for women and low performers and academic gains were larger for courses needing numerical or mathematical skills.

Third, legalization of marijuana is likely to increase the number of teen users. Research from Oregon Research Institute conducted in 2017 showed that teenagers who were already using marijuana prior to legalization increased their frequency of use significantly afterwards. Research from New York University, published in 2014, indicated that many high school students normally at low risk for marijuana use (e.g., non-cigarette-smokers, religious students, those with friends who disapprove of use) reported an intention to use marijuana if it were legal. Medical researchers and practitioners have warned us that legalization carries great dangers, particularly for vulnerable and at-risk youth between 15 and 24 years of age.

Age of restriction

Marijuana legalization policy across Canada is a top-down federal initiative driven largely by changing public attitudes and conditioned by the current realities of the widespread use of marijuana, purchased though illicit means.

Setting the age of restriction, guided by the proposed federal policy framework, has turned out to be an exercise in “compromise” rather than one focused on heeding the advice of leading medical experts and the Canadian Medical Association (CMA). In a 2016 submission to the government, the CMA argued that 25 would be the ideal age for legal access to marijuana, as the brain is still developing until then, but that a lower minimum age of 21 should be considered — to discourage children from purchasing marijuana from organized crime groups.

The report argued that: “Marijuana use is linked to several adverse health outcomes, including addiction, cardiovascular and pulmonary effects (e.g., chronic bronchitis), mental illness, and other problems, including cognitive impairment and reduced educational attainment. There seems to be an increased risk of chronic psychosis disorders, including schizophrenia, in persons with a predisposition to such disorders.” In fact, the minimum age for purchasing and possessing marijuana is going to be age 18 in Alberta and Quebec, and 19 in most other provinces. Getting it “out of high schools” was a critical factor in bumping it up to age 19 in most provinces.

Every Canadian province is complying with the federal legislation, but — in our federal system – it’s “customized” for each jurisdiction.

The Canadian Western provinces — Alberta, British Columbia and Saskatchewan —have opted for regulating private retail stores, while Ontario and the Maritime provinces (Nova Scotia, New Brunswick and P.E.I.) are expanding their liquor control commissions to accommodate retail sales of cannabis. High school teachers, as of September 2018, may be battling a spike in marijuana use and greater peer pressure to smoke pot on the mistaken assumption that it is “harmless” at any age.

Clamping down in schools

For high school principals and staff, this will be a real test.

By September 2018, the old line of defence that using marijuana is illegal will have disappeared. Recreational marijuana will be more socially acceptable. The cannabis industry will be openly marketing its products. High school students who drive to school will likely get caught under new laws prohibiting motor vehicle use while impaired by drugs or alcohol. Fewer students are likely to abstain when it is perfectly legal to smoke pot when you reach university, college or the workplace. We have utterly failed, so far, in getting through to the current generation of teens, so a much more robust approach is in order.

“Be firm at the beginning” is the most common sage advice given to beginner teachers. Clamping down on teen marijuana use during and after school hours will require clarity and firm resolve in the year ahead — and the support of engaged and responsible parents.

Legalization of recreational marijuana is bound to complicate matters for Canadian high schools everywhere. Busting the “Weed Myths” should not be left to doctors and health practitioners. Pursuing research-based, evidence-informed policy and practice means getting behind those on the front lines of high school education.

Source: https://theconversation.com/marijuana-at-school-loss-of-concentration-risk-of-psychosis-90374 January 25th 2018

National Families in Action (NFIA) was founded in Atlanta in 1977, to protect children from drugs.   It led a national effort to help parents  prevent the marketing of drugs and drug use to children and helped them form parent groups to protect children’s health.

Today NFIA publishes the weekly Marijuana Report, an update on major news affecting marijuana across the US.  NFIA has worked continuously for many years.    Tobacco and alcohol cause enough problems in the US and it’s unwise to add a third addictive drug.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Source: http://www.poppot.org/2015/05/22/national-families-of-action-states-marijuana-policy />

 

 

 

 

 

 

The percentage of drivers testing positive for marijuana or other illegal drugs is increasing, according to a new report. In 2013 and 2014, 15.1 percent of drivers tested positive for drugs, up from 12.4 percent in 2007.

The findings come from the Governors Highway Safety Association. The group found 38 percent of people who died in auto accidents in 2013 and were tested had detectable levels of potentially impairing drugs – both legal and illegal – in their system. That percentage is almost the same as those testing positive for alcohol, CNN reports.

The most common drugs detected were marijuana (34.7 percent) and amphetamines (9.7 percent), which includes nasal decongestants and drugs to treat attention deficit hyperactivity disorder.

“Alcohol-impaired driving is still a big deal, but we have paid more attention to it than to drug-impaired driving and it’s time to pay more attention to drug-impaired driving,” said report author James Hedlund. He notes drunk driving has been decreasing as drugged driving increases.

He noted one reason for the rise in drugged driving could be that “marijuana use is increasing, driven in parts by the states that legalized marijuana for medicinal and recreational use, and the second is that prescription painkiller use has gone up substantially.”

The report found 6.9 percent of people killed in auto accidents had hydrocodone in their system, while 3.6 percent had detectable levels of oxycodone, 4.5 percent had benzodiazepines (found in anti-anxiety and anti-depression drugs), and 4.5 percent had cocaine.

“Alcohol is the deadliest drug we have by practically any metric…and alcohol in combination with [marijuana] is particularly malignant,” Dr. Gary Reisfield, professor of psychiatry at the University of Florida, told CNN.

The report recommends that states train law enforcement officers to recognize the physical and behavioral signs associated with different substances.

Source:  www.drugfree.org 1st October 2015

The Food and Drug Administration has issued warning letters to “high CBD” hemp oil vendors, stating that their products are unapproved drugs that often don’t contain any active ingredient.

list of firms that were issued warning letters for marketing “unapproved drugs for the diagnosis, cure, mitigation, treatment, or prevention of diseases” was posted on the FDA’s website to warn consumers about these mostly hemp-derived products. Capsules, dog treats, e-liquids and oils all claiming to have CBD tested either negative or very low for cannabinoids.

Many of these companies claim on their websites that their products are completely legal because they are made from hemp and don’t have any psychoactive properties. The truth is they exist in a legal vacuum as long as they don’t market their products as drugs, which is why the FDA has stepped in.

The Industrial Hemp Farming Act of 2013 amended the Controlled Substances Act (CSA) to exclude industrial hemp from the definition of “marijuana,” loosening the restrictions on strains of Cannabis sativa that are very low in THC. This has facilitated cultivation of hemp in the U.S., but a great deal of hemp still gets imported (1,138 metric tons in 2011) everyday from China, Canada and the EU. Before 2013, essentially all the hemp used for its fiber and seed was imported and regulated by the DEA. Since the Marijuana Tax of 1937, it has been legal to cultivate hemp with a DEA license, but the tight restrictions meant almost no one did it.

Cannabis sativa that is low in THC may still contain CBD, so whole-plant extracts of hemp grown for industrial purposes could make a product semi-rich in CBD, if done correctly. A cheap extraction process like steam distillation done on a sample of plant material that is mostly stalks and leaves might extract some CBD, but it can also extract unsafe pesticides and toxins absorbed from the soil.

Cannabis thrives in toxic soils and accumulates heavy metals, so the soils it grows in needs to be carefully selected and tested for pollutants. If grown in another country, especially one with lax environmental regulations, hemp products might be highly contaminated.

Source:  http://www.hightimes.com/  7th March 2015

 

 

 

PHOENIX (December 18) — New state data from the U.S. Substance Abuse and Mental Health Services Administration shows that Colorado now leads the nation in marijuana use across all age levels and, most disturbingly, in the 12-17 and 18-25 age categories. Marijuana legalization advocates have persistently claimed that marijuana use will not rise with legalization, and that legalization will have little bearing on under-age use. This latest data from the U.S. Department of Health and Human Services proves otherwise.

“Sadly for Colorado’s youth, the data now substantiates the theory that increased availability leads to increased use — despite being assured the contrary by legalization advocates. Arizonans should pay close attention,” said Seth Leibsohn, chair of Arizonans for Responsible Drug Policy. “In Colorado, teen marijuana use has not only increased since legalization, it is now the highest in the nation — more than 73 percent higher than the national average. For those who recommended a ‘wait-and-see’ approach based on Colorado’s experience, the results are in and they are not good. It should be crystal clear, in Arizona and any other state considering legalizing marijuana, that going down the same path would be devastating to our youth and our communities.”

“According to this data, Colorado is not only number one for marijuana use but also ranks near the top in the nation in its use of other illicit drugs,” said Sheila Polk, vice chair of Arizonans for Responsible Drug Policy. “Serious peer-reviewed science warns us that marijuana does significant harm to the developing adolescent brain, causes impaired memory and judgment, lowers IQ and increases school drop-out rates. It is unconscionable to unleash this harmful drug on Arizona’s youth.”

###

About Arizonans for Responsible Drug Policy

The Arizonans for Responsible Drug Policy PAC was formed to actively oppose any initiative that would legalize the recreational use of the drug marijuana in the state of Arizona. Visit www.arizonansforresponsibledrugpolicy.org for more information.

Source:  Press Release 18th Dec 2015  melissa@axiompublicaffairs.com

Drug law enforcement is not just unnecessarily punitive but discriminately so. We’d all be better without it.  No that’s not what I think.  It’s the received wisdom of drug legalisation campaigners that George Soros has been putting his billions behind.  Law enforcement is more harmful by far than the effects of the noxious drugs its purpose is to control, they claim.

In any debate on drugs policy I take part in, figures are routinely flung at me of the number of people unjustly incarcerated in the United States or unjustly convicted in the UK.  Suddenly I find democracy US/UK style is racist and as evil as ISIL.

Typically, I am told that half of all federal prisoners in the US are in for drug offences and that this “…punishment falls disproportionately on people of colour”. “Blacks make up 50 percent of the state and local prisoners incarcerated for drug crimes” is typically claimed and rarely challenged.

As for our punitive drugs laws on this side of the pond, I am also routinely informed that  “…roughly 87,000 people are being wrongly convicted every year” some 70 per cent of which are for that delightful social drug cannabis, strangely about the same number as the total number of prison places in the UK.

Fact and fiction could not be more different.  A recently published written answer shows that in any of the last 5 years, the number of people sentenced to more than a year in prison in the UK for  a Class A drugs offence can be counted on two hands ; a sentence of over 6 months for class B drugs (which include cannabis)  can be counted on one hand.

Though  cautions, discharges and rehabilitation orders far exceed all other sentencing (which includes fines and community orders) outraged liberals like Sam Bowman of the Adam Smith Institute irresponsibly persist in  their hyperbole that, “prohibition means putting thousands of people in jail, giving criminal records to hundreds of thousands of others”.

The law is unjust they insist, despite the absence of any evidence for this, that  ‘possession’ arrests damage lives, fill prisons and waste police resources.

The latest to get behind the gross social injustice banner is Bill de Blasio, the Democrat Mayor of New York City  (the first Democrat since 1993).  Under this banner and persuaded that the enforcement of federal marijuana laws doesn’t so much protect minority communities as harm them, he’s instructed the New York Police Department not to enforce them.

The reality is otherwise, however, as John Walters and David W Murray explain  here. As here in the UK the actual risk of arrest while using marijuana in the States is stunningly low – about one arrest for marijuana possession for every 34,000 joints smoked.

Drug arrests are far from being a significant portion of law-enforcement activity.  Possession arrests for marijuana do not fill US prisons – fewer than 0.3 per cent of the total of those incarcerated in state prisons (which is where most US inmates are incarcerated) in fact.  And many of these have “pled down” from more serious offences.

Nor, as we are supposed to uncritically believe,  are African-Americans the directly targeted victims of the drug laws; race is not the driver of “disparate impact”.

Walters and Murray will not make themselves popular for explaining why there are more black drug arrests. The simple facts are that: African Americans are more engaged in drug trafficking; their drug use “often occurs in areas with intensive policing, such as urban street corners” which means, yes,  that the risk of arrest for African-Americans is indeed higher than for whites, whose use of drugs is typically less conspicuous.

Nor is it just drug-related crime where there are racial disproportions in arrests and incarcerations. As they point out, the same is true for almost all crimes.  This difficult fact leaves the outraged liberal in the ‘logical’ but untenable position of having to believe that  virtually all efforts to combat crime must be “wars on communities of colour”.

The trouble is with this specious racial discrimination position is that the only solution would be to decriminalise all crime.  Where that leaves minority communities is far from protected.

Mayor de Blasio only has to look at recent crime rises California to understand this.

There, the recent passing of Proposition 47 has reduced or eliminated prison time for certain drug and stolen property crimes,  the most visible impact of which is its effect on drug possession cases; making California the first state to make drug possession crimes misdemeanours instead of felonies.

The impact has been immediate. It appears to be responsible for an increase in crime figures.

In certain areas, aggravated assault is up 9.9 per cent since the law came into effect and burglary by a whopping 30.7 per cent in the same period.

Myths about the harm of punitive enforcement are myths.  The price of no enforcement is severe – much more crime which threatens all our well being, whatever our colour.

By Kathy Gyngell 

Source: conservativewoman.co.uk   19th Dec.2014

Theresa May has walked into the sunshine again after a few awful days. Such is the magic of politics.

Just a few days ago, much of her shine as a tough and competent Home Secretary had worn off.  Her child abuse inquiry appeared doomed before it had begun. With the prospect of an expensive and endless white elephant ahead (what the experience of both the Saville and Chilcot probes portend) as she apologised to the victims, she must have been ruing the day she ever gave into their demands.

Yes, it was just a few days ago that she could please no one. Her insistence on opting back into the European Arrest Warrant infuriated her backbenchers and left the Eurosceptic public astonished. Could she really be giving carte blanche for us to be picked off our own streets and dumped in a Latvian, Czech or Bulgarian gaol where due process, habeas corpus and so forth are, despite their EU member status, still  pretty much conspicuous for their absence?

Then at the nadir of her fortunes up she comes smiling.  All thanks to the Daily Mail – and very grateful she should be to them too – she was handed Norman Baker’s scalp on a plate.  Overnight she became the new scourge of the Lib Dems, to the joy of her party and her admirers.

Nick Clegg, the Mail discovered, had encouraged the BBC to give airtime to the drug-legalising organisations (Transform and Release) to promote the controversial and highly (Lib Dem) spun Home Office report pushed by his Home Office placeman, one Norman Baker.

This report was already proving a severe embarrassment to her, adding to her woe.

Opening up the drug debate to ‘legalising liberals’ had never been of her choosing.  She was bounced into it.  At the time of the Home Affairs Select Committee report and Nick Clegg’s demand for a Royal Commission on Drugs Policy (a couple of years ago now), giving permission to her then (Lib Dem) Minister, Jeremy Browne, to go on a jaunt (sorry, I meant an international drugs policy fact-finding mission) must have seemed infinitely preferable.

But instead of subsequently chucking into the bin the contents of this ‘jolly’ (to the drug-loving countries of Uruguay, Colorado, the Czech Republic and Portugal, to name but a few of those selected)  – which she should and could have done on the basis of its questionable content – she sat on it.

At that moment she made herself a hostage to fortune. Specifically, she made herself a hostage to Norman Baker, the conspiracy theorist, ageing hippy and would-be rock star that Clegg had chosen to replace the more cogent and intelligent Mr Browne.

But for the Daily Mail scoop, but for their forensic research, which exposed the report’s dodgy facts, but for their pinning the whole thing on Calamity Clegg and Barmy Baker, Theresa would today still be doing daily battle with an unbearably smug Norm and seeming rather less than in charge.

Indeed, she still might be blissfully unaware of the civil servant porkies they so glibly presented in her name as ‘evidence-based’ policy  – of the false facts it took the Mail to expose.

“It is clear that there has not been a lasting and significant increase in drug use in Portugal since 2001”, the civil servants, who drafted the report with Baker’s blessing, asserted.     Except there has been.

In the decade following decriminalisation, school-age drug use, as the Mail correctly pointed out, rose from 12 per cent to 19 per cent of the age group. Back in 1995 (before decriminalisation) only 8 per cent of this group had tried drugs.

Either the researchers were not going  to let an inconvenient fact get in the way of good story or they just didn’t bother to do their homework. That’s why anyone interested in reading through the entire report is advised to put down the rose-tinted spectacles accompanying it.

It skates through medical marijuana in the United States, legalisation of cannabis in Colorado and Uruguay, drug consumption rooms, ‘assisted heroin injecting’ and other liberal ‘harm reduction’ but ethically dubious policies in other countries. It ignores swathes of criticism of these back door to legalisation policies and lacks the rigour and detail to provide a credible basis for discussion.

Predictably, it treats Portugal’s ‘dissuasion commissions’ on a par with the USA’s longstanding, 2,500-strong federal wide and much respected drug court network – of which independent evaluations have demonstrated positive outcomes and over whose time span  cocaine use has dropped by 75 per cent.

Frankly, Mrs May is lucky to no longer have this dodgy dossier still hanging round her neck.  With all the plaudits that have been raining down on her – from the Mail to the Telegraph – for being the longest-serving Home Secretary since Rab Butler, for surviving one of the most difficult senior roles in Cabinet, for regaining the top spot in the battle for the Tory succession in the regular poll of activists by Conservative Home and accompanying fulsome praise –  she’d do well to reflect how lucky she has been.

She might think it is time to sharpen up those micro-management skills that The Times’s Francis Elliott rather kindly supposes to have kept her on top.  The Daily Mail scoop and the Lib-Dems’ shenanigans and spin surrounding the publication of a report that she herself signed off show these much-hyped qualities have not been much in evidence.

A bit more micro-management and she’d have sent her civil servants back to the drawing board and queried their ‘facts’, instead of letting Norman’s day arrive and allowing the report’s publication on the very same day as ‘loopy’ Caroline Lucas’s much heralded and Russell Brand-supported parliamentary drugs debate.

For all her apparent skills this is far from her first mistake. She made a far worse one on her first day in office when she signed off Harriet Harman’s horrendous and costly Equalities Act without any further discussion or reflection.  She didn’t stop there but published her own ‘right on’ Contract for Equalities.  There is nothing that ‘We’re all in this together’ does not cover.

I guess we just have to be thankful she didn’t then, this last week, under Lib Dem pressure for ‘evidence-based policy’,  action equal access to illicit drug use by decriminalising it.  Her featherbrained new feminist minister Lynne “gay marriage” Featherstone (responsible for crime prevention) is bound to suggest it. Be warned.

Source: By Kathy Gyngell conservativewoman.co.uk    6th November 2014

A lack of guidance from the U.S. Environmental Protection Agency frustrated Colorado’s efforts to decide how to handle pesticides and pot.

State regulators have known since 2012 that marijuana was grown with potentially dangerous pesticides, but pressure from the industry and lack of guidance from federal authorities delayed their efforts to enact regulations, and they ultimately landed on a less restrictive approach than originally envisioned.

Three years of e-mails and records obtained by The Denver Post and dozens of interviews show state regulators struggled with the issue while the cannabis industry protested that proposed limits on pesticides would leave their valuable crops vulnerable to devastating disease.

Last year, as the state was preparing a list of allowable substances that would have restricted pesticides on marijuana to the least toxic chemicals, Colorado Department of Agriculture officials stopped the process under pressure from the industry, The Post found.

DENVER, CO – AUGUST 19: Lucas Targos the head grower at L’Eagle sprays the marijuana plants in their cultivation room on Wednesday August 19, 2015. They spray with neem oil which helps combat the spider mites and mildew. He sprays the plants every 7-10 days. This was the last spraying before they go into the flowering stage. Targos was an organic food farmer before working with marijuana. (Photo by Cyrus McCrimmon/The Denver Post )

“This list has been circulated among marijuana producers and has been met with considerable opposition because of its restrictive nature,” wrote Mitch Yergert, the CDA’s plant industry director, shortly after the April 2014 decision. “There is an inherent conflict with the marijuana growers’ desire to use pesticides other than those” that are least restrictive.

Another year passed before regulators publicly released a draft list of pesticides allowed on marijuana plants — a broader, less restrictive list than initially proposed. That only occurred after the city of Denver began quarantining plants over concerns that pesticides posed a health hazard.

The marijuana industry “was the biggest obstacle we had” in devising any effective pesticide regulation, said former Colorado agriculture commissioner John Salazar.

“We were caught between a rock and a hard spot,” he said. “Anything we wanted to allow simply was not enough for that industry.”

The U.S. Environmental Protection Agency, which regulates pesticides, offered the state little advice about what to do because marijuana is an illegal crop under federal law.

“We tried to work with the EPA, to figure out what to do, but we got nothing,” Salazar said.

With little federal guidance and no science to know which pesticides might be safe for consumers, the department made pesticide inspections a low priority, records show.

“Our current policy is to investigate complaints related to MJ (marijuana), otherwise focus on higher priorities,” Laura Quakenbush, the CDA’s pesticide registration coordinator, wrote to a colleague in a December 2012 e-mail.

Critics say the state bowed to industry’s influence.

“Colorado has given the marijuana industry way too much power, way too much control over the political process,” said Kevin Sabet, co-founder of Smart Approaches to Marijuana, a group that opposed legalizing marijuana.

“Regulators are trusting the industry and saying, ‘Show us how to regulate you.’ They’re putting their trust in the industry,” said Samantha Walsh, a lobbyist who has represented marijuana-testing labs and the unions representing workers at cannabis cultivation facilities.

“There’s been foot-dragging in much of the industry,” she said. “It’s a failure of the government to step in and institute these practices.”

State officials say it was important to take into account industry concerns.

“CDA felt there was a need to further explore all possibilities of how best to regulate and identify what pesticides could be legally used on marijuana. During this process, we believe we have identified a better way forward than what we originally proposed in April of 2014,” Yergert told The Post.

The agency is just now preparing for regular inspections of marijuana growers using pesticides, Yergert said, something it already does for other commercial users such as crop-dusting businesses. In July, the CDA began visiting marijuana businesses for “compliance assistance” that focuses on education and training.

And last week, Yergert said, the agency began a new rule-making process to formalize the list of pesticides growers can use.

Heavy-hitting pesticides

Marijuana and pesticides hit CDA’s radar in 2012 when a former employee of the Kine Mine, then a medical marijuana dispensary in Idaho Springs, complained to the state of not being given protective clothing to spray growing plants.

CDA inspectors found two heavy-hitting pesticides — Floramite and Avid — were used on dozens of cannabis plants.

The CDA cited the business with violating a pesticide’s label restrictions. The state was unable to do more because it had not yet determined which pesticides could and could not be used on cannabis in Colorado.

As commercial grow operations spread after recreational pot sale became legal in 2014, complaints continued to flow. Sales of recreational and medical marijuana reached nearly $700 million last year and topped $540 million through July. There are 600 pot-growing licenses in Denver alone.

“I think everyone thought marijuana growers were a bunch of organic growers who would never use pesticides on pot, but that’s definitely not the case,” said Mowgli Holmes, a molecular geneticist at Phylos Bioscience and board member of the Cannabis Safety Institute in Oregon. “A lot of this pesticide use is new and driven by commercial pressures.”

When large numbers of cannabis plants are grown indoors and in close proximity, they are vulnerable to mites and powdery mildews, which can destroy a crop quickly.

To date, there have been 24 inquiries into pesticide complaints involving marijuana businesses, CDA officials said.

Another early complaint came in 2012 when a consumer said a popular cannabis leaf wash for killing bugs claimed to be “99.9999%” water that worked because of an ionic charge.

A state lab found it actually contained high levels of “pyrethrin, a plant-based insecticide that requires EPA registration,” wrote Quakenbush, the CDA’s pesticide registration coordinator.

Officials determined that because the product label did not say that it contained a pesticide, they lacked authority over its use, according to e-mails. The state referred the mislabelling problem to the EPA for investigation, and the state did not look further into the issue.

But the case led state inspectors to send several e-mails to the EPA seeking guidance on how to handle the emerging pesticide problem. Officials also asked whether pesticides allowed on tobacco would suffice. The state received no response, according to e-mails the state provided.

The federal agency responded in an e-mail to The Post that “over the past several years, the U.S. EPA has had interactions with representatives from the Colorado Department of Agriculture on this issue” but provided no details.

Health impact

Colorado initially wanted to do as New Hampshire did, allowing only the least harmful pesticides to be used in marijuana cultivation.

Those included neem, cinnamon and peppermint oils — products so nontoxic that federal registration is not required and no tolerance level is necessary for their residues.

By restricting cannabis growers to those products, Colorado could adapt its rules over time as more information became known about the health impact of chemical residues from pesticides.

Before the sale of recreational pot became legal in 2014, “a majority in the industry’s underground didn’t have very sophisticated practices and were using lots of toxic things they shouldn’t have on a regular basis,” said Devin Liles, who runs The Farm cultivation facility in Boulder.

In April 2014, the CDA laid out the issue: “For food crops, a tolerance (of pesticide residues) must be established. No tolerances have been established for marijuana because they are not recognized as a legal ‘agricultural crop.’ “

Put simply, many pesticides that the marijuana industry was already using — some of them allowed by the EPA on food crops — were to be off the table.

Small, informal working group meetings were held in March and April. Liles said other members of a group on which he participated immediately were worried.

“Some operations were really concerned because what they were using was now on the chopping block,” he said, “and they didn’t know if it would become more restrictive later.”

The proposed rule was published, and a meeting during which stakeholders could speak was scheduled for that May.

“The Colorado Department of Agriculture does not recommend the use of any pesticide not specifically tested, labeled and assigned a set tolerance for use on marijuana because the health effects on consumers are unknown,” the proposed rule said.

Then in late April 2014, soon after CDA issued the proposed rule — and following two meetings where officials heard the industry’s reaction — the agency pulled the plug on its rule-making process.

“The termination will allow the agency more time to meet with the representative group of stakeholders and further review the impacts of the proposed rule,” according to the portion of the Colorado secretary of state’s website where the hearings are tracked.

“We continued to have conversations without having any resolution,” Ron Carle ton, CDA’s former deputy commissioner, said in an interview. “The industry was of the opinion they needed the same kind of access to pesticides that other growers were using, that this low-level stuff wouldn’t do it.”

CDA and the marijuana industry continued to wrangle. That June, CDA shared copies of an early, broadened draft list of approved pesticides with at least one industry group.

“The list never meant much because it was always in draft form, never formalized or finalized, and rule-making never occurred,” Michael Elliott, executive director of the Marijuana Industry Group, told The Post in an e-mail.

At a CDA meeting with businesses in December, Elliott said growers were frustrated because they did not believe the state was giving them the tools necessary to fight the problems they faced.

“We need clean product, and we have a huge list of things to test for and failure could literally shut down a business,” he said.

Meanwhile, CDA continued its policy of not checking to see what pesticides marijuana growers were using unless someone complained.

“To date, CDA has not actively sought to inspect and enforce the provisions of the (Colorado) Pesticide Applicator’s Act on marijuana producers,” Yergert, CDA’s plant industry director, wrote in a memo for a meeting in December. The Pesticide Applicator’s Act is the state’s authority to enforce EPA pesticide laws.

The delays had Yergert worried that CDA’s inaction could be problematic.

“The last thing that I want is somebody to get sick and they say it was due to pesticide use” and that the state knew about it, he said at the December meeting with industry representatives. “None of us wants to be in front of that train.”

Turning up the heat

While state regulators and the industry debated how pesticides should be regulated, Denver was about to turn up the heat.

Denver firefighters conducting routine safety inspections of marijuana growhouses in early 2014 discovered some growers were burning sulphur as a fumigant to kill mites. Firefighters say that’s a fire hazard.

Once stopped from using the dangerous substance, the growers turned to pesticides, and firefighters noticed cabinets full of odd-sounding chemicals.

“They will do something to protect these million-dollars worth of plants,” said Lt. Tom Pastorius. “We stopped one issue with the sulphur. But that just led to a whole different issue.”

The city’s environmental health department responded by quarantining about 100,000 plants in March after application logs showed pesticides they knew little about. City health officials met with CDA and learned of the agency’s draft list of pesticides it said were OK to use.

The meeting prompted the state to release the list publicly. It was the first time growers say they were fully aware of what they could and could not use.

“At that time, we didn’t want to put the list out,” said John Scott, CDA’s pesticide program manager. “We were still working on the rule itself.”

But once Denver had quarantined the plants, “we felt like it couldn’t wait,” Scott said.

Pesticides on the list have labels so broadly written that the state determined their use on marijuana is permissible. However, CDA also says it does not recommend their use because no one knows whether the pesticides are safe when used on marijuana.

Three of the growers whose plants were quarantined fought back in court, suing the city for allegedly overextending its authority. Pesticides, the businesses argued, were the purview of CDA, not the city.

The industry also turned to the Colorado legislature and had a last-minute amendment designed to stop Denver’s enforcement added to a bill about marijuana tax revenues, according to documents and interviews.

It’s not the only example of marijuana growers looking toward the Capitol for help. Also during the last session, several legislators tried but failed to pass a law that would have removed pesticides entirely from the list of ingredients on marijuana product packages.

The enforcement amendment, which ensured that pesticide oversight of marijuana growers would stay with the state, was tacked on from the Senate floor on the day before it adjourned.

“The worry was that communities could basically ban the use of some pesticides based on emotional responses rather than factual ones,” said Sen. Jerry Sonnenberg, R-Sterling, the amendment’s sponsor. “It was to codify that the state was in charge, not Denver, not any city.”

The impetus for his amendment, Sonnenberg said, came primarily from conversations with three lobbyists who records show are with the Marijuana Industry Group.

Sonnenberg’s re-election committee had accepted about $1,000 in contributions from the three since 2010, according to state campaign finance records. In that time, he’s accepted about $1,800 from all marijuana-related contributors, records show. All contributions Sonnenberg received since 2010 totaled $49,900, according to state filings.

More broadly, the industry has spent at least $421,000 on lobbying on various cannabis-related issues this year, state reports show. In contrast, utility giant Xcel Energy has spent $230,640, according to the company. The city eventually won in court, but the amendment passed as well. Subsequent enforcement actions by Denver occurred at the retail level, far from where plants are actually covered in pesticides and where CDA’s pesticide authority extended.

The city declined to comment on the legislature’s action.

“What was most frustrating about what happened in Denver is that the city went from not participating in the statewide conversation and doing absolutely nothing to placing holds on businesses,” Elliott at MIG said in an interview. “We would have appreciated having them involved in the state process and perhaps having worked out more local solutions instead of coming down quickly with holds.”

Elliott paused, then offered: “That said, I understand why they reacted the way they did. They identified a safety issue and took action. Very little has been going on on this issue on a statewide level.”

Source: The Denver Post   4th Oct. 2015

Comments below from David Evans Esq., a lawyer and special adviser to the Drug Free America Foundation, re the suggestion that marijuana could assist in treating opiate addiction.

WHAT ARE THE PHYSICAL AND BEHAVIORAL ADVERSE EFFECTS OF USING “MEDICAL” MARIJUANA WHILE IN OPIATE TREATMENT?

Memory defect (short and long term) – how are they to remember compliance issues and new problem solving? Masks other mental health issues – anxiety, PTSD, Bipolar

Marijuana use impacts the brain, creates a delay in learning skills to NOT have substance use in life.

In order for change to occur, person must acknowledge loss of control – how can someone do this when control is still lost with marijuana?

Changes in coordination, mood swings, memory/learning problems

Marijuana use deters the return to normal brain functioning and the continued drive for more substances and stimuli in the pleasure seeking area of the brain.

Marijuana use is A-motivational – knocks out drive and ambition

Continued use maintains Arrested Development – low emotional maturity – the maturity level is stumped when start using substances

Recovery – means not using drugs

THC suppresses neurons in information processing system of the hippocampus, the part of the brain that is crucial for learning memory and integration of sensory experiences with emotions and motivations. Learned behaviors, which depend on the hippocampus, deteriorate after chronic exposure

· Because marijuana use impacts learning a person falls behind in accumulating intellectual, job, or social skills. This can directly translate to need for more treatment both with intensity and length

Users have trouble sustaining and shifting their attention in and registering, organizing and using information.

Increase risk of motor vehicle/work accidents

For more detailed information log on to a paper in Support of the UN Drug Conventions: The Arguments Against Illicit Drug Legalisation and Harm Reduction also by David Evans.

Source: https://nationalallianceformarijuanaprevention.files.wordpress.com/2011/12/2009-un-drug-conventions-the-argument-against-legaliztion.pdf

Human cells mutated faster than expected after exposure to e-cigarettes

· Previous studies have found e-cigarette smoke causes less cancerous damage than tobacco

· New York University exposed human cells and mice to e-cigarette smoke compared to filtered air

· They found the cells mutated much faster than expected

· The team warns this shows vaping is not as risk-free as we may think By MIA DE GRAAF HEALTH EDITOR FOR DAILYMAIL.COM

PUBLISHED: 16:16, 29 January 2018 | UPDATED: 10:21, 30 January 2018 Vaping causes DNA mutations which lead to cancer, a new study warns.

Researchers subjected cultured human bladder and lung cells to e-cigarette vapor which is designed to avoid the carcinogenic by products of tobacco.

They found the cells mutated and became cancerous at a much higher rate than expected, and mice exposed to the smoke also suffered significant DNA damage.

The New York University team warns their findings, published today, bring into question the popular belief that vaping nicotine is a safe alternative to smoking it in cigarettes.

It comes just days after the Food and Drug Administration rejected Philip Morris’s ‘healthy’ iQOS electronic vaping product, saying it is not healthier than tobacco.

New York University exposed human cells and mice to e-cigarette smoke compared to filtered air, and they found vaping did increase the rate of cancerous DNA mutations

E-cigarette smoke (ECS) delivers nicotine through aerosols without burning tobacco.

While tobacco smoke contains nitrosamines and many carcinogenic chemicals from burning, ECS contains nicotine and some relatively harmless organic solvents.

As a result, ‘vaping’, as it is colloquially called, has been promoted as not carcinogenic; a safer substitute for tobacco.

A recent study even found that e-cigarette smokers had 97 percent less lung carcinogens in their body fluids compared to tobacco smokers.

However, experts warn that does not mean it is safe and void of cancer risk.

The new study by Moon-shong Tang, of the environmental medicine department, was an investigation into the belief that other products in tobacco – not nicotine – are the ones that cause cancer and other health woes.

They subjected mice and human cells to the vapor.

They concluded that although vaping delivers fewer carcinogens than tobacco smoke, e-cigarette smokers might have a higher risk than non-smokers of developing lung and bladder cancers and heart diseases.

Last week the FDA voted unanimously against Philip Morris International’s claims that its e-cigarette could predict lower rates of diseases and death in humans.

The penlike device heats Marlboro-branded sticks of tobacco but stops short of burning them.

It is already sold in more than 30 countries and Philip Morris aims to make it the first ‘reduced risk’ tobacco product ever sanctioned by the US.

FDA clearance would mark a major milestone in efforts by both the industry and government officials to provide alternative tobacco products to US smokers.

The adult smoking rate has fallen to an all-time low of 15 percent, though smoking remains the nation’s leading preventable cause of illness and death.

Source: http://www.dailymail.co.uk/health/article-5325945/Vaping-causes-cancer-new-study-warns.html 29th Jan 2018

Filed under: Health,Nicotine :

John Hickenlooper, D-Colo., and Sen. Cory Gardner, R-Colo., don’t seem to care much about the toll recreational marijuana imposes on Colorado. Each reacted with righteous indignation to the Trump administration’s decision to rescind the Obama administration’s lax pot policies.

“It’s not a black market anymore. It’s not a criminal activity, and we would hate for the state to go backwards,” Hickenlooper said Thursday, expressing concern about the potential for more federal enforcement against our state’s illegal marijuana industry.

Gardner asserted his duty Thursday to protect the state’s “right” to sanction, host, and profit from an industry that flagrantly violates federal law to the detriment of traffic safety, federal lands, children, and neighboring states that are burdened by Colorado pot. Never mind that even the Obama policy emphasized a need for federal enforcement against drugged driving, damage to kids and neighboring states, and the presence of cartels and pot on federal land. Somehow, Colorado has a right to avoid these federal enforcement measures even the Obama administration wanted.

Colorado politicians need to stop pandering and start leading, which means telling the truth about the severely negative consequences of big commercial pot.

Hickenlooper, Gardner, and other politicians tell us everything is rosy, but that’s not what we hear from educators, cops, social workers, doctors, drug counselors, parents, and others in the trenches of the world’s first anything goes marijuana free-for-all. It is not what we see in the streets.

If Hickenlooper and Gardner cared to lead on this issue, they would tell the world about the rate of pot-involved traffic fatalities that began soaring in their state in direct correlation with the emergence of legal recreational pot and Big Marijuana. They would talk about Colorado’s status as a national leader in the growth of homelessness, which all major homeless shelter operators attribute to commercialized, recreational pot.

They would talk about the difficulty in keeping marijuana from crossing borders into states that don’t allow it. They would spread the words of classroom educators and resource officers who say pot consumption among teens is out of control.

Honest leaders would talk about illegal grow operations invading neighborhoods and public lands. They would stop selling false, positive impressions about a failed policy for the sake of “respecting the will of voters” who made a mistake. They would not follow public perception but would lead it in a truthful direction.

Hickenlooper says legalization has eliminated illegal pot in Colorado, which is laughable to men and women who enforce the law and talk to us.

El Paso County Sheriff Bill Elder speaks of more than 550 illegal rural home-grow operations in El Paso County alone.

Mayor John Suthers — Colorado’s former U.S. attorney, attorney general, district prosecutor and state director of corrections — speaks of hundreds of illegal pot operations in Colorado Springs he hopes to raid. We could go on with countless accounts of leading law enforcers who describe illegal pot activity that exceeds limits of departmental budgets and personnel.

That’s the small stuff, relative to the massive black market Colorado’s legalization attracts to federal property.

Dave Condit, deputy forest and grassland supervisor for the Pike-San Isabel and Cimarron-Comanche National Grasslands, recently accompanied Forest Service officers on the raid of a Mexican cartel’s major grow operation west of Colorado Springs. It was among at least 17 busts of cartel operations in the past 18 months. He describes the type of operation mostly based in Mexico, before legalization made Colorado more attractive. Condit said the agency lacks resources to make a dent in the additional cartel activity in the region’s two national forests.

“It was eye opening to put on the camouflage and sneak through the woods at 4 in the morning,” Condit told The Gazette’s editorial board Friday. “I had no idea the scope of these plantations. These are huge farms hidden in the national forests. The cartels de-limb the trees, so there is some green left on them. Other trees are cut down. They fertilize the plants extensively, and not all these fertilizers and chemicals are legal in this area.

“This is different than anything we have experienced in the past. These massive plantations are not the work of someone moving in from out of state who’s going to grow a few plants or even try to grow a bunch of plants and sell them. These are massive supported plantations, with massive amounts of irrigation. The cartels create their own little reservoirs for water. These operations are guarded with armed processors. They have little buildings on site. The suspects we have captured on these grows have all been Mexican nationals.”

Condit said the black market invading Colorado’s national forests has grown so large the entire budget for the Pike and San Isabel forests would not cover the costs of removing and remediating cartel grows in the forests he helps supervise.

“There’s a massive amount of resource damage that has to be mitigated,” Condit said. “You’ve got facilities and structures that have to be deconstructed. We would need to bring in air support to get materials out of there. There are tens of thousands of plants that have to be destroyed.”

Condit hopes the Colorado Legislature will channel a portion of marijuana proceeds to the Forest Service to help pay for closure and reclamation of cartel operations.

“For every plantation we find, there are many more,” Condit said.

Authorities captured only two cartel suspects in the raid Condit witnessed, and others escaped by foot into the woods.

“This operation had a huge stockpile of food. Hundreds and hundreds of giant cans (of food), and stacks of tortillas two or three people could not consume in months,” Condit said. “So it appeared they were planning to bring in a large crew for the harvest. I wouldn’t have thought you could hide something like that in our woods, but you can.”

Officers seized a marijuana stash and plants worth an estimated $35 million that morning. Merely destroying the plants presented a significant expense.

“Whether you’re a recreational shooter, a weekend camper, or you’re going to walk your dog in the woods, you should be concerned,” Condit said. “Some of these people have guns. If you stumble into $35 million worth of illegal plants, I’d be concerned. We are concerned for our own personnel.”

That’s not the view of either Colorado senator, other pandering politicians or the state’s top executive. From their offices Washington and Denver, they see things quite differently.

“Now the people who cultivate marijuana, the people who process marijuana, the people who sell marijuana are not criminals,” Hickenlooper said Thursday. “They’re not committing any crimes.”

No black market? No crimes? Tell the cartels. They come to Marijuana Land in the wake of Amendment 64, wisely betting state leaders will defend their risky and unprecedented law no matter what. They count on politicians to look the other way, so they can tell the world their new system works.

The Colorado Springs Gazette is a sister newspaper to the Washington Examiner. This editorial originally ran there.

Source: Colorado Springs Gazette Editorial Board | Jan 10, 2018, 9:23 AM

Studies show that approximately 187,000 people die each year from drug overdose. A majority of these deaths are attributed to opioids, one of the most powerful drugs available both legally and illegally. According to the National Institute on Drug Abuse, over 90 Americans die each day from opioids overdose, a tragic and alarming statistic.

While many have images of underground drug peddlers, cartels, and violent gangs, a large part of opioid abuse is actually from prescription drugs. The National Institutes of Health (NIH) notes that almost one-third of patients that are prescribed opioids for chronic pain misuse them. Around 80 percent of heroin users first abused prescription opioids.

The unfortunate reality is that the roots of the opioid crisis run deep. Arguably, it is a greater challenge to combat the “legal” side of the crisis–prescriptions, pharmaceutical companies, and the like–than the illegal side. This is because, despite stricter Center for Disease Control (CDC) guidelines, rules and regulations are extremely difficult to enforce.

What’s more, it is increasingly hard to monitor over-prescriptions, prescription fraud, and documentation abuses. Pharmacies are compelled to trust doctors’ judgments, and physicians are sometimes unaware that patients have been prescribed drugs by other physicians for the same medical problem. Despite repeated attempts to solve these problems, no viable answer has been found.

However, thanks to the promising prospects of blockchain technology, all of these issues may be solvable. One company, BlockMedX, is working on an HIPAA compliant system that provides a completely secure, end-to-end solution that will go to great lengths in solving the opioid and prescription drug epidemic.

BlockMedX’s Ethereum Based Solution

BlockMedX’s solution revolves around creating a streamlined, secure system for drug providers, pharmacists, and patients. It runs on the Ethereum blockchain, creating a cryptographically secure prescriber-to-patient platform.

Prescriptions are securely transmitted and recorded by the blockchain, in conjunction with platform’s token (MDX). Each token is paired with a unique and specific prescription, thus validating the origin of the prescription. In order to access the prescription, physicians, pharmacies, and patients will have to login to a website that is connected to the blockchain.

Each physician will have access to their personal prescribing history as well as the history of each patient they interact with. This will help them detect prescription abuse, which often takes place when a patient sees multiple doctors to receive medication for one issue. Physicians will also be able to make use of BlockMedx proprietary verification system, which ensures that only the actual physician can digitally sign prescriptions.

Once a physician issues a prescription it is sent in the pending state, where it awaits a signature by BlockMedx. When the prescription is digitally signed on the blockchain, it is moved to the approved state. It is then logged on the blockchain as an immutable record. Physicians can therefore know for certain that their patients have been issued the correct prescription. They can also track its progress, allowing them to make sure that their prescriptions aren’t defrauded or misused.

Pharmacies are given a list approved prescriptions that can be accepted, declined, or revoked. They will then open the BlockMedX decentralized app to access the network.

The pharmacy can view the prescription information as well as the patient’s full prescription history. They will then accept or decline each prescription on the queue, based on the information they have.

If a prescription is accepted, the pharmacy will receive the MDX tokens sent by the physician and deposited into its wallet. Then, pharmacies can receive payment from the valid patient via MDX tokens.

From a regulatory perspective, the blockchain provides unique advantages that the current pharmaceutical system doesn’t have. Because all transactions, from physician to pharmacy to patient, are logged on the public ledger, any third party entity can audit the transactions. For governments and regulatory bodies, this means there is an easy and secure way to enforce existing regulations and requirements. By viewing the immutable record stored on the blockchain, authorities can track prescription abuses and prosecute them accordingly.

From the perspective of physicians and pharmacies, the blockchain provides a way to view prescription histories in order to help prevent fraud and over-prescribing. The BlockMedX platform allows all parties involved, including third party auditors, to crack down on the opioid crisis in an efficient and streamlined manner.

Source: https://www.techworm.net/2018/01/blockchain-startup-can-help-prevent-medical-prescription-abuse.html 7th January 2018

Public Health and Safety Communities Applaud Move

DOJ Decision Will Dry Up Money To Marijuana Industry

(January 4, 2018 – Alexandria, VA) – The Department of Justice will announce today it will rescind lax marijuana policy guidance to US Attorneys (the so-called “Cole Memo”) and instead allow US Attorneys to exercise discretion in going after marijuana cases. The new memo will not call for arresting users or others with low-level involvement in marijuana, but instead makes investing in the marijuana industry a risky move.

“This is a good day for public health. The days of safe harbor for multi-million dollar pot investments are over,” said Kevin A. Sabet, a former Obama Administration drug policy adviser who is now head of the anti-legalization group Smart Approaches to Marijuana (SAM). “DOJ’s move will slow down the rise of Big Marijuana and stop the massive infusion of money going to fund pot candies, cookies, ice creams, and other kid-friendly pot edibles. Investor, banker, funder beware.”

The Cole Memo and its compliance was blasted by the nonpartisan Government Accountability Office (GAO) in a 2016 report. The lead GAO author stated that DOJ “has not documented its plan for monitoring the effects of the state marijuana legalization.” A recent poll also found that when voters had more choices than just legalization or prohibition, support for legalization fell by 30%. Most voters were comfortable with laws removing criminal penalties for use but not legalizing sales, which the Cole Memo permitted.

“The Cole Memo had been waived around by money-hungry pot executives for years, searching for legitimacy among investors and banks,” remarked former Congressman Patrick J. Kennedy, a SAM Honorary Advisor. “It’s time we put public health over profits. This is a sensible move that now must be followed up with action so we can avoid a repeat of the nightmare of Big Tobacco.”

“Marijuana, along with alcohol and tobacco, are the three drugs we need to stop our youth from trying,” said Dr. Robert DuPont, the first Director of the National Institute on Drug Abuse and second White House drug czar. “DOJ is doing the right thing by putting a stop to this wink and nod policy of allowing marijuana legalization.”

Corinne Gasper, who lost her daughter Jennifer to a driver high on marijuana, stated, “All too often, marijuana has been seen as benign. An industry not unlike Big Tobacco has downplayed its harms, aided by laws allowing officials to look the other way. For the sake of so many families, I hope those days are now over.”

SAM, a non-profit organization founded by a former member of Congress and a former Obama Administration drug policy advisor, applauded the news. SAM’s Science Advisory board consists of more than a dozen top researchers in the field of marijuana policy ranging from institutions such as Harvard and Johns Hopkins.

Dr. Stuart Gitlow, the former President of the American Society of Addiction Medicine, stated, “This is the right move by DOJ. To protect public health, we must choke the large amounts of funding spent by Big Marijuana to hook kids on highly potent THC products.”

Justin Luke Riley, the Denver-based leader of the Marijuana Accountability Coalition stated, “Recovery from addiction is so much harder when you are bombarded with the kind of pot commercialization we see here in Colorado. DOJ should be applauded for trying to put a stop to the shameless promotion and advertising that is killing our community.”

Ron Brooks, the former head of the National Narcotics Officers Association Coalition, stated, “This is the kind of leadership that will save lives. For too long law enforcement has been handcuffed by vague and unenforced policy guidance.”

Will Jones, a DC-resident who is fighting for social justice in minority communities commented, “Since the Cole Memo was released, the pot industry has relentlessly opened more pot shops in poorer, communities of color. Arrests are even higher now in many jurisdictions than before legalization.”

“Focusing enforcement resources on incarcerating low-level, nonviolent offenders will always be wrong and counterproductive,” said Kevin Sabet, President of SAM. “But there is an urgent need for Federal officials to reassert targeted control over an exploding industry that is undermining public health and safety in our communities.

This is a major blow to an industry that is corrupting our politics and lying to voters in a steadfast pursuit to put profit over public health and safety. Today’s policy change will undoubtedly extend a chilling effect we have seen on marijuana legalization initiatives across the nation this year, and – hopefully – encourage lawmakers to stop and look at what science tells us about the unintended consequences of legal marijuana.

Like the tobacco industry before it, well-heeled lobbyists from the marijuana industry have been touting marijuana commercialization as the panacea for every contemporary challenge we face in America, but the truth is, the health and safety costs caused by the commercialization of cannabis are outweighing any tax revenues collected.”

Source: Press Release from SAM: info@learnaboutsam.org. 4th January 2018

WASHINGTON – China’s Ministry of Public Security last week announced scheduling controls on two fentanyl precursor chemicals – NPP and 4ANPP, substances that can be used to make illicit drugs. The scheduling controls will take effect on February 1, 2018 and is the result of the ongoing collaboration between the Drug Enforcement Administration and the Government of China and their shared commitment to countering illicit fentanyl-class substances.

“Fentanyl compounds significantly contribute to the current opioid crisis in the United States. By stemming the chemicals used to make these substances, this latest Chinese scheduling action will help save lives,” said DEA Acting Administrator Robert W. Patterson. “This scheduling action is an important step and a testament to the progress our countries are making together in addressing this epidemic.”

DEA and Chinese officials maintain frequent contact to collaborate and share data on the threat from fentanyl-class substances and their impact on the United States. Information-sharing includes scientific data, trafficking trends, and sample exchanges. This dialogue has resulted in improved methods for identifying and submitting deadly substances for government control.

The Chinese Government previously controlled four fentanyl-class substances – carfentanil, furanyl fentanyl, valeryl fentanyl, and acryl fentanyl – which took effect on March 1, 2017, and another four new psychoactive substances/fentanyl-class substances – U-47700, MT-45, PMMA, and 4,4’ DMAR – which took effect on July 1, 2017. Source: U.S. Drug Enforcement Administration dea@public.govdelivery.com 5th Jan 2018

University of Michigan’s annual drug abuse survey – Monitoring the Future University of Michigan’s annual drug abuse survey, Monitoring the Future, were released today showing that the percentage of teens using over-the-counter (OTC) cough medicine containing dextromethorphan (DXM) to get high remains at just 3 percent, the lowest level recorded for teen cough medicine abuse since 2015. When first reported in 2006, teen abuse of these OTC cough medicines was nearly 6 percent, but has declined significantly since then.

Since 2006, the rate of teen OTC cough medicine abuse has decreased by 44% (from 5.4% to 3%).

Over the past decade, the Consumer Healthcare Products Association (CHPA) has worked to help reduce teen DXM abuse by employing three strategies: increasing parent engagement in abuse awareness and prevention; heightening teen perceptions of the risks and social disapproval of medicine abuse; and limiting teen access to DXM through age-18 sales restrictions in states. In 2008, CHPA member companies voluntarily placed a “PARENTS: Learn About Teen Medicine Abuse” icon on the packaging of cough medicines containing DXM. The icon serves as a mini public service announcement for parents, making them aware of cough medicine abuse at the point-of-sale and point-of-use and directing them to StopMedicineAbuse.org – a well-established website and abuse prevention campaign aimed at engaging parents and community leaders about teen abuse of OTC cough medicine.

“Public policy and education are both vitally important to combating teen OTC cough medicine abuse,” said CHPA president and CEO Scott Melville. “This is why CHPA has long supported state efforts to limit teen access to DXM and has worked to increase parental awareness through our Stop Medicine Abuse education campaign, while at the same time, ensuring continued access for millions of families who responsibly use medicines containing DXM.” CHPA also collaborates with the Partnership for Drug-Free Kids to target teens who are most likely to abuse DXM based on their online search activity and to provide them with accurate information about the consequences of abusive behavior. Teens are directed to visit WhatIsDXM.com to learn more.

“The Partnership for Drug-Free Kids welcomes the data from this year’s Monitoring the Future Survey showing no year-to-year increases in high school students’ misuse of over-the-counter cough and cold remedies,” said Partnership president and CEO Fred Muench. “For nearly a decade now, the Partnership and CHPA have collaborated on a digital media prevention effort targeting this behavior – and we have seen steady and significant declines over this period in teens’ misuse of OTC cough medicine to get high. It’s compelling evidence that smart, strategic prevention initiatives can work, and can deliver real benefits to teens and their families.”

Additionally recognizing that retailers play a critical role in abuse prevention, this year CHPA launched a new Pharmacists & Retailers page on the StopMedicineAbuse.org site, where retailers can download or order free materials.

Please visit StopMedicineAbuse.org for more information about teen DXM abuse, the retailer education materials, and other helpful resources for parents and community leaders.

The Consumer Healthcare Products Association (CHPA) is the 136-year-old national trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines and dietary supplements. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system $6-$7, contributing a total of $102 billion in savings each year. CHPA is committed to empowering consumer self-care by preserving and expanding choice and availability of consumer healthcare products. chpa.org

Source: https://www.businesswire.com/news/home/20171214006254/en/New-Results-Annual-Survey

America’s worsening opioid crisis has caused life expectancy to fall for the second year running for the first time in more than half a century.

The average life expectancy in the US is now 78.6 years – down by 0.1 years, figures from the National Center for Health Statistics (NCHS) found.

It is the first consecutive drop in life expectancy since 1962-63 and surpasses the previous one-year dip in 1993 at the height of the Aids epidemic.

America’s opioid addiction crisis – caused by the over-prescription of opioid based painkillers – has been blamed for the trend.

The addiction sees patients turning to heroin and other substances when their doctors stops issuing prescription medication.

Synthetic opioids such as fentanyl, which has flooded the US drugs market and is 100 times more powerful than heroin, are thought to be behind the dramatic increase in overdoses among heroin users.

“The key factor in all this is the increase in drug overdose deaths,” said Robert Anderson, from the NCHS, who said the two-year drop was “shocking”.

US president Donald Trump has called the crisis a “public health emergency” and pledged to tackle illegal drug trades.

He said: “Nobody has seen anything like what is going on now.

“As Americans, we cannot allow this to continue. It is time to liberate our communities from this scourge of drug addiction.”

Official figures show the number of people who died from a drug overdose in 2016 was 63,000 – 21 per cent higher than the previous year and three times the rate in 1999.

Opioid-related overdoses increased by 28 per cent, causing 42,249 deaths, mostly in the 25-to-54 age group.

Average male life expectancy has fallen 0.2 years – average female life expectancy is unchanged at 81.1 years.

A continued decline in life expectancy in 2017 would represent the first three-year fall in the US since the outbreak of Spanish flu 100 years ago.

Death rates fell for seven leading causes of death, including heart disease, cancer, stroke and diabetes, however an ageing population meant Alzheimer’s related deaths increased by 3.1 per cent and suicide rates increased by 1.5 per cent.

Source: http://www.telegraph.co.uk/news/2017/12/22/americas-opioid-crisis Dec.22.2017

There’s no future for salmon in Northern California’s Emerald Triangle.

On California’s northern coast are three counties that marijuana aficionados call the Emerald Triangle. In their view, the growers there have perfected a strain of cannabis that has high potency and consistently high quality. Result: There are many growers, most tending their crops in remote corners of these mountainous, heavily wooded counties.

This produces serious environmental damage. In Humboldt County where the largest amount of Emerald Triangle marijuana is grown, the sheriff’s office conducted an aerial survey and counted 4,000 visible outdoor grows, nearly all of them illegal. (California was the first of 22 states to permit medical use of marijuana, so some grows were established to serve users who have permit cards.)

The illegal grows are usually carved out of forest land (often national forests or acreage owned by timber companies). Typically, the growers clear-cut the trees on the land they want to use, then bulldoze it to their specifications. Next, they divert a nearby stream to provide the one to six gallons required daily by each plant. They then fertilize the plants, causing runoff. This is followed by a generous dose of rat poison.

The upshot: The U.S. Fish and Wildlife Service a week ago declared that stream diversion by marijuana plantations was robbing the rivers that the streams feed of enough cool water for Coho salmon to breed, thus threatening their survival. California’s north coast is big salmon country, for both sport and commercial fishing. The declaration earned banner headlines in the local press.

This week the USFWS said that it was considering seeking a “Threatened” status for the fisher, a native cousin to the weasel. Many fishers have been dying after ingesting the rat poison put out by marijuana planters.

Disruption of the soil for planting the crop and for cutting roads to some of the remote locations causes runoff that silts the area’s rivers—another preventable threat to the already endangered native salmon and steelhead.

In the area, a multi-agency task force has raided, on average, one marijuana plantation a week since January 2013. The biggest one, in August this year, yielded 10,000 plants; most have had several hundred. The plants are destroyed. The “harvest” often yields cash, weapons, and, sometimes other drugs (although multi-drug hauls tend to found in in-town dealer houses).

In addition to the cost of the raids, “grows” on public land require public resources to clean up and restore the affected area.

Environmentalists in the three counties are quick to run to the battlements and declare all-out war any time the state Transportation Department sets out to widen a highway. With the regular pot plantation raids, however, they are as silent as mice. Occasionally, one will opine in an interview that the problem would go away if marijuana were made legal. This outcome seems unlikely. Large companies might buy up some tracts for growing (along with getting the necessary permits and paying taxes); however, not every small grower will be able to compete; hence, the likelihood they would feed a black market, selling to heavy users at below-market prices. Thus, one problem would yield to another.

Source:  American spectator 9th October 2014
www.drugwatch.org

Summary:

Several studies have demonstrated that the primary active constituent of cannabis, delta-9-tetrahydrocannabinol, induces transient psychosis-like effects in healthy subjects similar to those observed in schizophrenia. However, the mechanisms underlying these effects are not clear. A new study shows that this active ingredient increases random neural activity, termed neural noise, in the brains of healthy human subjects. The findings suggest that increased neural noise may play a role in the psychosis-like effects of cannabis.

Cannabis. Credit: © olyas8 / Fotolia

Several studies have demonstrated that the primary active constituent of cannabis, delta-9-tetrahydrocannabinol (∆9-THC), induces transient psychosis-like effects in healthy subjects similar to those observed in schizophrenia. However, the mechanisms underlying these effects are not clear.

A new study, published in the journal Biological Psychiatry, reports that ∆9-THC increases random neural activity, termed neural noise, in the brains of healthy human subjects. The findings suggest that increased neural noise may play a role in the psychosis-like effects of cannabis.

“At doses roughly equivalent to half or a single joint, ∆9-THC produced psychosis-like effects and increased neural noise in humans,” explained senior author Dr. Deepak Cyril D’Souza, a Professor of Psychiatry at Yale School of Medicine.

“The dose-dependent and strong positive relationship between these two findings suggest that the psychosis-like effects of cannabis may be related to neural noise which disrupts the brain’s normal information processing,” added first author Dr. Jose Cortes-Briones, a Postdoctoral Associate in Psychiatry at Yale School of Medicine.

The investigators studied the effects of ∆9-THC on electrical brain activity in 24 human subjects who participated in a three-day study during which they received two doses of intravenous ∆9-THC or placebo in a double-blind, randomized, cross-over, and counterbalanced design.

If confirmed, the link between neural noise and psychosis could shed light on the biology of some of the symptoms associated with schizophrenia.

“This interesting study suggests a commonality between the effects on the brain of the major active ingredient in marijuana and symptoms of schizophrenia,” stated Dr. John Krystal, Editor of Biological Psychiatry. “The impairment of cortical function by ∆9-THC could underlie some of the cognitive effects of marijuana. Not only does this finding aid our understanding of the processes underlying psychosis, it underscores an important concern in the debate surrounding medical and legalized access to marijuana.”

Source:   http://www.sciencedaily.com/releases/2015  3 Dec.2015

Abstract


To present a summary of current scientific evidence about the cannabinoid, cannabidiol (CBD) with regard to its relevance to epilepsy and other selected neuropsychiatric disorders. We summarize the presentations from a conference in which invited participants reviewed relevant aspects of the physiology, mechanisms of action, pharmacology, and data from studies with animal models and human subjects. Cannabis has been used to treat disease since ancient times. Δ9-Tetrahydrocannabinol (Δ9-THC) is the major psychoactive ingredient and CBD is the major non-psychoactive ingredient in cannabis. Cannabis and Δ9-THC are anticonvulsant in most animal models but can be proconvulsant in some healthy animals.

The psychotropic effects of Δ9-THC limit tolerability. CBD is anticonvulsant in many acute animal models, but there are limited data in chronic models. The antiepileptic mechanisms of CBD are not known, but may include effects on the equilibrative nucleoside transporter; the orphan G-protein-coupled receptor GPR55; the transient receptor potential of vanilloid type-1 channel; the 5-HT1a receptor; and the α3 and α1 glycine receptors. CBD has neuroprotective and anti-inflammatory effects, and it appears to be well tolerated in humans, but small and methodologically limited studies of CBD in human epilepsy have been inconclusive.

More recent anecdotal reports of high-ratio CBD:Δ9-THC medical marijuana have claimed efficacy, but studies were not controlled. CBD bears investigation in epilepsy and other neuropsychiatric disorders, including anxiety, schizophrenia, addiction, and neonatal hypoxic-ischemic encephalopathy. However, we lack data from well-powered double-blind randomized, controlled studies on the efficacy of pure CBD for any disorder. Initial dose-tolerability and double-blind randomized, controlled studies focusing on target intractable epilepsy populations such as patients with Dravet and Lennox-Gastaut syndromes are being planned. Trials in other treatment-resistant epilepsies may also be warranted.

Source:   Epilepsia  Volume 55Issue 6pages 791–802June 2014

 

The truth is it can indeed mean trouble, especially for young people.

These days, it’s become fairly square to criticize marijuana and its rush toward legalization. Twenty-three states have condoned the drug in some form, with four permitting recreational use, and Massachusetts is set to vote on permitting it next year. The proposed federal CARERS Act of 2015 would let states legalize medical marijuana without federal interference and demote pot from a Schedule I drug — one with high abuse potential — to Schedule II. The path toward nationwide decriminalization is looking unobstructed.

But underscoring the incredible momentum to legalize marijuana is the misconception that the drug can’t hurt anybody. It can, especially young people.

The myth that marijuana is not habit-forming is constantly challenged by physicians. “There’s no question at all that marijuana is addictive,” Dr. Sharon Levy tells me. She is the director of the Adolescent Substance Abuse Program at Boston Children’s Hospital, one of a few programs designed to pre-emptively identify substance use problems in teens. At least 1 in 11 young adults who begin smoking will develop an addiction to marijuana, even more among those who use the more potent products that are entering the market.

Levy speaks of an 18-year-old patient who had started smoking marijuana several times a day in 10th grade, dropped out of high school, and been stealing money from her parents. “She and her family were at their wits’ end trying to find appropriate treatment in a health care system that doesn’t consider addiction to marijuana a serious problem,” Levy says. “We are simply not prepared for the fallout of marijuana legalization.”

Such perspectives have been obfuscated by those who might gain from legalization. “People strongly defend marijuana because they don’t want legalization to be derailed,” says Jodi Gilman, an assistant professor at Harvard Medical School with the Center for Addiction Medicine.

An insistence on the banality of the drug is especially dangerous among younger smokers, a population with an epidemic level of pot use. According to the most recent National Survey on Drug Use and Health, the use of tobacco and alcohol among 12-to-17-year-olds has fallen in the past year, but habitual use of marijuana among those 12 and up is increasing.   “If you go into a high school and ask the classroom, ‘Are cigarettes harmful? Is alcohol harmful?’ every kid raises their hands,” Gilman says. “But if I ask, ‘Is marijuana harmful?’ not a hand goes up.”

To bring balance to a narrative driven by pro-legalization campaigns, Gilman and others are interested in leveraging data to show pot’s real effects. Last year, Gilman published research on 18-to-25-year-olds that showed differences in the brain’s reward system between users and non-users. (“I got a lot of hate mail after that,” Gilman says.) And data supporting the hazards keep accumulating. Recently Gilman found that in a group of college students, smokers had impaired working memory even when not acutely high.

Physician concern for marijuana’s acceptance isn’t because doctors are a stodgy bunch — their scepticism is rooted in science and in history. In the 1950s, nearly half of Americans smoked tobacco, a level of adoption that rendered its health hazards invisible. Meanwhile, the corporate forces that drove cigarette smoking to its ascendancy actively subverted those that governed public health.

While marijuana has not been definitively shown to cause cancer or heart disease, its harmful cognitive and psychological effects will take time to capture in studies. The underlying biochemistry at work suggests deeply pathologic consequences. Tetrahydrocannabinol (THC) in marijuana attaches to receptors in the brain that subtly modulate systems ordinarily involved in healthy behaviors like eating, learning, and forming relationships. But THC — which has been increasing in potency in legal products being sold in places like Colorado — throws the finely tuned system off balance.

“Smoking pot turns the volume on this system way, way up,” says Jonathan Long, a research fellow at the Dana-Farber Cancer Institute.

Each hit of THC rewires the function of this critical cognitive system: Early evidence in mice has shown that repeated exposure to THC causes these receptors to disappear altogether, blunting the natural response to positive behaviors and requiring higher doses to achieve the same effect. Marijuana exploits essential pathways we’ve evolved to retrieve a memory, to delicately regulate our metabolism, and to derive happiness from everyday life.

Medical science at its best operates independently of forces that drive the market and its associated politics. It was science that eventually curtailed the power of Big Tobacco and prevented nearly 800,000 cancer deaths in the United States between 1975 and 2000. As marijuana marches toward the same legal status as cigarettes, its potential hazards will require equal attention by science.    The argument here isn’t whether marijuana should be legal. There are champions on either side of that debate. Instead, should the drug become widely available, it’s to our detriment to blindly consider marijuana’s legalization a victory worthy of celebration. We must be cautious when societal shifts can affect health, especially among our most vulnerable populations.

Source: http://www.bostonglobe.com/magazine/2015/10/08/can-please-stop-pretending-marijuana-harmless/MneQebFPWg79ifTAXc1PkM/story.html

 

Erie police and local hospitals are dealing with a rash of overdoses involving the synthetic marijuana known as K2, which police said is highly addictive and is sold in packages such as this packet, which was recently seized in a drug investigation. The packets typically sell for $20 to $30, according to police.

A form of synthetic marijuana is filling local emergency rooms. Authorities said seven teenagers ended up in hospitals after attending a party Thursday night in Erie that involved the drug, known as K2. At least some of the teens were later transferred to a Pittsburgh hospital for follow-up care.

Shortly before 1 p.m. Friday, Erie police and EmergyCare were sent to the 400 block of East 15th Street on a report of a K2 overdose. The call was separate from the call about the party, whose location police are still investigating. The incidents were among the latest in what Erie police and hospital officials are calling a recent spike in overdoses involving K2, a form of synthetic marijuana also known by such names as Spice and Potpourri.  Officials said they have no reports of fatal K2 overdoses in Erie, but that the overdoses trigger erratic and dangerous behavior. The emergency room at UPMC Hamot had handled more than 20 K2 overdose cases in the past week as of Friday morning, said Ferdinando Mirarchi, D.O., the hospital’s medical director of emergency medicine.

“It’s kind of like marijuana on steroids,” he said. Saint Vincent Hospital has also treated K2 overdose cases, including some of the teenage victims from the Thursday night party, said James Amsterdam, M.D., the hospital’s chief medical officer.  Erie police and the Erie County District Attorney’s Drug Task Force are investigating.

 K2 is a mixture of spices or plant material that is typically sprayed with a synthetic compound that is chemically similar to THC, the psychoactive ingredient in marijuana. K2 is typically sold in small bags and marketed as incense that can be smoked, according to information on the Partnership for Drug-Free Kids website and is treated with chemicals that come from overseas, said Mike Nolan, of the Erie Bureau of Police Drug & Vice Unit.

The K2 that is winding up in Erie is made in clandestine labs in the West and is treated with chemicals that come from overseas, said Lt. Mike Nolan, of the Erie Bureau of Police Drug & Vice Unit.

“The thing is, you don’t know what (the chemical) is,” he said.  The packets of K2, under various names, are typically sold out of stores illegally, police said. They cost $20 to $30 for a 3-to-5-gram packet, city drug investigators said.

Investigators are learning from users that K2 is highly addictive, Nolan said. One person in a recent investigation told detectives that the only thing more addictive than K2 is heroin, he said. Unlike marijuana, which typically has a calming effect, K2 can produce hyper-excitability in those who smoke it, Hamot’s Mirarchi said. Users can get very agitated or very depressed, and then can develop seizures and respiratory problems, he said.

The more typical symptom of K2 overdose patients who come into the ER is excitability to the point of acting psychotic, Saint Vincent’s Amsterdam said. Users can be extremely violent, resulting in injury to themselves as well as to hospital staff, he said.  “It might take actual sedation and muscle paralysis to control the patient, in which case they need to be put on a ventilator,” Amsterdam said. “Some patients can present, after the excited state, more of an exhausted state. They could be hard to arouse, and could need airway protection.” Amsterdam said there is no antidote, and the length of time it takes for the drug to wear off typically results in a two- to three-day hospital stay. “The frustrating thing is, these places don’t stop selling it,” Nolan said.

An amendment to Pennsylvania’s Controlled Substances, Drugs, Device and Cosmetic Act in 2013 included synthetic cannabinoids, which makes them illegal, and provided a list of specific chemicals, said former Erie County Assistant District Attorney Roger Bauer, who was recently hired as a deputy attorney general in Erie for the state Attorney General’s Office Drug Strike Force Section. Bauer prosecuted K2 cases for the District Attorney’s Office.

“Everyone knows what marijuana does to the body. These chemicals are clandestine manufactured. No one really knows what goes into them until after the fact. That’s why you have cases of people dying or getting high and acting in a different manner,” Bauer said.  Erie Police Deputy Chief Donald Dacus said his department is still actively investigating and serving search warrants on local businesses suspected of selling K2. Anyone who knows of anyone actively selling it is asked to call the bureau’s Drug & Vice Unit at 870-1199.

Source: Erie Times-News, Erie, Pa., Oct. 17, 2015.  

Filed under: Synthetics,USA :

The only thing green about that bud is its chlorophyll.

—By Josh HarkinsonBrett Brownell, and Julia Lurie

March/April 2014 Issue of Mother Jones

You thought your pot came from environmentally conscious hippies? Think again. The way marijuana is grown in America, it turns out, is anything but sustainable and organic. Check out these mind-blowing stats, and while you’re at it, read Josh Harkinson’s feature story, “The Landscape-Scarring, Energy-Sucking, Wildlife-Killing Reality of Pot Farming.”

 

Sources: Jon Gettman (2006), US Forest Service (California outdoor grow stats include small portions of Oregon and Nevada), Office of National Drug Control Policy, SF Public Utilities Commission, Evan Mills (2012).

UPDATE: Beau Kilmer of the RAND Drug Policy Research Center argues that the government estimates of domestic marijuana production used in this piece and many others are in fact too high. Kilmer’s research, published last week, suggests that total US marijuana consumption in 2010 (including pot from Mexico) was somewhere between 9.2 and 18.5 million pounds.

Source:  https://www.motherjones.com/environment/2014/03/marijuana-pot-weed-statistics-climate-change/

Back to top of page

Powered by WordPress